Medical Gemcitabine Hydrochloride Anti Cancer CAS 122111-03-9 Purity 99%

 

Medical Comsumables Gemcitabine hydrochloride Anti-cancer CAS 122111-03-9 Purity 99%

 

 

• Product description

• Product name	Gemcitabine hydrochloride
  CAS No.	122111-03-9
  Molecular Formula	C9H12ClF2N3O4
  Molecular weight	299.66
  Grade Standard	Medicine Grade
  COA	Avaliable

 

Product intoduction:

Gemcitabine hydrochloride is a 2′-deoxycytidine hydrochloriode having geminal fluoro substituents in the 2′-position. An inhibitor of ribonucleotide reductase, gemcitabine hydrochloride is used in the treatment of various carcinomas, including non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.

 

 

Product application:

1) Acute myeloid leukemia: Whether be used alone or in combination with other antineoplastic drugs, daunorubicin is indicated for the treatment of various tumor staging of acute myeloid leukemia; it is also indicated for the treatment of promyelocytic leukemia.
2) Acute lymphocytic leukemia: Although daunorubicin has a high remission rate for the treatment of acute lymphocytic leukemia, but because of its serious side effects and there are other effective therapeutic methods available, daunorubicin is only applied to those cases that have become resistant to other drugs. Co-administration of daunorubicin hydrochloride with p rednisone and vincristine has been proven to be very successful in the acute phase of acute lymphocytic leukemia.
3) Other tumors: Daunorubicin showed a good effect on the treatment of neuroblastoma and rhabdomyosarcoma.

 

•